AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDICAL
Biogen Idec Q1 profit rose 66%
The biotech made 40 cents a share ex items, 6 cents over views. Sales rose 24% to $542 mil. Its flagship multiple sclerosis drug Avonex led with a 29% rise in sales to $355 mil. Sales of its cancer drug Rituxan rose 20% to $134 mil. Biogen plans to file for FDA approval of its MS drug Antegren in midyear, ahead of schedule. Shares of Biogen Idec rose 3.5% to 59.
Cigna income up 27%, lifts views
The health insurer beat Q1 views of $1.86 cents a share ex items by 40 cents. Revenue fell 4% to $4.72 bil, also over estimates. The firm, still in a turnaround after 2 years of falling profits, said health care profits rose 53%. It expects to make Q2 net income of $155 mil-$185 mil vs. $151 mil expected and raised its '04 forecast. Shares slipped 0.5% to 64.51.
Genta plunges on FDA questions
Federal regulators called the effectiveness claims for Genta and Aventis's skin cancer ...
- Fundamental Review for Biogen Idec Inc.
- Press release article from: M2 Presswire February 15, 2007 700+ words
...Cambridge-based Biogen Idec earned $108.6 million, or 32 cents per share, for...licensing agreement, Biogen Idec earned $184 million, or 53 cents per share -- just...items. Shares of Biogen Idec fell 99 cents, or nearly 2 percent...
- SUNESIS, BIOGEN IDEC IN CANCER DEAL WORTH $21 MILLION UP FRONT By Karen...
- Magazine article from: BIOWORLD Today September 8, 2004 700+ words
...the collaboration with Biogen Idec, Sunesis is working on...and July 28, 2004.) Biogen Idec is working to expand the...the end of this year. Biogen Idec's stock (NASDAQ:BIIB) rose 43 cents on Tuesday, to close...
- Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming By Jennifer...
- Magazine article from: BIOWORLD Today July 28, 2005 700+ words
Biogen Idec Inc. beat Wall...million, or 10 cents per share, for...estimate of 36 cents. The Cambridge...said one reason Biogen Idec surpassed estimates...Today. Shares of Biogen Idec (NASDAQ:BIIB) rose 66 cents Wednesday to close...
- Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming.(Financial...
- Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...Staff Writer Biogen Idec Inc. beat Wall...million, or 10 cents per share...estimate of 36 cents. The Cambridge...said one reason Biogen Idec surpassed estimates...Shares of Biogen Idec (NASDAQ:BIIB) rose 66 cents Wednesday to...
- BIOGEN IDEC EARNINGS LOWER THAN WALL STREET'S FORECAST.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron March 4, 2003 700+ words
...first time as a combined entity, Biogen Idec Inc. missed consensus earnings estimates by 8 cents, posting pro forma earnings per...year adjusted EPS totaled $1.22. Biogen Idec's generally accepted accounting...
- Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena.
- Magazine article from: BIOWORLD Today Morrison, Trista January 5, 2007 700+ words
...Cambridge, Mass.-based Biogen Idec will acquire all issued...Mass.-based facility. Biogen Idec's stock (NASDAQ:BIIB) inched up 42 cents on the news to close at...nearly $17 billion, but Biogen Idec Director of Public Affairs...
- Tysabri Events For Biogen Idec Overshadow Year-End Figures.
- Magazine article from: BIOWORLD Today Pihl-Carey, Karen February 17, 2006 700+ words
...Tysabri market withdrawal, Biogen Idec Inc. reported strong...for the quarter of 48 cents - a penny above consensus...blockbuster potential, Biogen Idec has fared OK. Shortly...paving the way for Biogen Idec and its partner Elan...
- Biogen Idec Increases Profits But Misses 4Q EPS Estimates.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron February 16, 2007 700+ words
...Washington Editor Biogen Idec Inc. turned in...per share of 53 cents for the quarter...accounting principles, Biogen Idec produced fourth...per share of 32 cents, doubling that...company produced 63 cents per share for the...business development, Biogen Idec CEO ...